Abiopharma

亞太地區企業加快推進SAP現代化轉型

New Form 424B2 - WELLS FARGO & COMPANY/MN <b>Filed:</b> 2026-05-01 <b>AccNo:</b> 0001839882-26-022490 <b>Size:</b> 112 KB

New Form FWP - CITIGROUP INC <b>Filed:</b> 2026-05-01 <b>AccNo:</b> 0000950103-26-006632 <b>Size:</b> 349 KB

New Form 424B8 - NOMURA HOLDINGS INC <b>Filed:</b> 2026-05-01 <b>AccNo:</b> 0001104659-26-054073 <b>Size:</b> 1 MB

New Form 424B2 - WELLS FARGO & COMPANY/MN <b>Filed:</b> 2026-05-01 <b>AccNo:</b> 0001839882-26-022489 <b>Size:</b> 1 MB

BRITISH AMERICAN TOBACCO P.L.C. (BTI) Files Form 6-K

New Form 424B2 - EDISON INTERNATIONAL <b>Filed:</b> 2026-05-01 <b>AccNo:</b> 0001193125-26-201253 <b>Size:</b> 547 KB

New Form 424B2 - BANK OF AMERICA CORP /DE/ <b>Filed:</b> 2026-05-01 <b>AccNo:</b> 0001918704-26-011792 <b>Size:</b> 1 MB

KalVista Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of KalVista Pharmaceuticals, Inc. - KALV

Paychex Declares a 10% Increase to Quarterly Cash Dividend

📋 BELANOFF JOSEPH K (Officer) plans to sell 40K shares of CORCEPT THERAPEUTICS INC (at $46.52 each, total $1.9M) Filed: May 01, 2026 | ID: 000014

New Form FWP - ROYAL BANK OF CANADA <b>Filed:</b> 2026-05-01 <b>AccNo:</b> 0000950103-26-006631 <b>Size:</b> 62 KB

New Form 424B2 - BANK OF MONTREAL /CAN/ <b>Filed:</b> 2026-05-01 <b>AccNo:</b> 0001214659-26-005409 <b>Size:</b> 528 KB

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-05-01 <b>AccNo:</b> 0001918704-26-011791 <b>Size:</b> 435 KB

New Form 424B2 - GOLDMAN SACHS GROUP INC <b>Filed:</b> 2026-05-01 <b>AccNo:</b> 0001193125-26-201243 <b>Size:</b> 423 KB